|
Market Closed -
Nasdaq
16:00:00 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 18.42 USD | +4.96% |
|
+4.63% | +5.32% |
| 09-09 | Summit Therapeutics Shares Rise After Upgrade From Jefferies | MT |
| 09-09 | Jefferies Upgrades Summit Therapeutics to Buy From Hold, Adjusts Price Target to $25 From $15 | MT |
Stock exchange
Quotes 5-day view: Summit Therapeutics Inc.
Delayed Quote Nasdaq
| 2026-09-08 | 2026-09-09 | 2026-09-10 | 2026-09-11 | 2026-09-14 | |
|---|---|---|---|---|---|
| Last | US$17.28 | US$17.54 | US$17.00 | US$17.55 | US$18.42 |
| Volume | 7,355,093 | 4,803,972 | 4,221,476 | 4,278,137 | 7,062,625 |
| Change | - | +1.50% | -3.08% | +3.24% | +4.96% |
| Opening | US$17.43 | US$18.21 | US$17.30 | US$17.20 | US$18.07 |
| High | US$17.69 | US$18.32 | US$17.62 | US$17.70 | US$18.83 |
| Low | US$16.97 | US$17.24 | US$16.80 | US$17.14 | US$17.97 |
Performance
| 1 day | +4.96% | ||
| 1 week | +4.63% | ||
| Current month | +35.24% | ||
| 1 month | +37.98% | ||
| 3 months | +31.48% | ||
| 6 months | +14.27% | ||
| Current year | +5.32% | ||
| 1 year | -2.75% | ||
| 3 years | +864.40% | ||
| 5 years | +187.81% | ||
| 10 years | +194.72% |
Volumes
marketsDaily volume
7,066,883
Estimated daily volume
7,066,883
Avg. Volume 20 sessions
6,252,776
Daily volume ratio
1.13
Avg. Volume 20 sessions USD
115,176,133.92
Record volume 1
156,896,100
Record volume 2
100,518,800
Record volume 3
89,815,400
Capital turnover ratio
0.01
Float rotation
0.04
Basic data
Market Cap (USD)
14,000,505,515
Net sales (GBP)
0
Net sales (USD)
0
Number of employees
265
Sales / Employee (GBP)
0
Sales / Employee (USD)
0
Free-Float
19.11%
Free-Float capitalization (USD)
2,675,407,732
Average Daily Capital Traded
1.11%
Indicators
Moving average 5 days
17.56
Moving average 20 days
14.63
Moving average 50 days
14.46
Moving average 100 days
15.58
Price spread / (MMA5)
-4.68%
Price spread / (MMA20)
-20.60%
Price spread / (MMA50)
-21.51%
Price spread / (MMA100)
-15.41%
STIM
RSI 9 days
71.08
RSI 14 days
66.98
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +4.63% | -2.75% | +864.40% | 14B | |
| +5.04% | +3.66% | +50.62% | +103.77% | 66.93B | |
| +1.64% | -0.18% | +34.67% | +76.81% | 61.97B | |
| -3.18% | -0.78% | -14.14% | +369.82% | 28.26B | |
| -0.37% | -1.18% | +25.44% | +10.98% | 24.59B | |
| +2.20% | -4.72% | +2.19% | -13.14% | 24.3B | |
| +1.15% | -1.17% | +17.56% | -21.92% | 19.41B | |
| -7.03% | -10.19% | +161.91% | +303.00% | 16.77B | |
| -2.16% | -3.36% | -7.35% | +496.96% | 14.18B | |
| +0.16% | -4.74% | +43.58% | +152.40% | 13.91B | |
| Average | +0.21% | -3.43% | +31.17% | +234.31% | 28.43B | |
| Weighted average by Cap. | +1.16% | -2.08% | +32.83% | +168.93% |
Historical Quotes: Summit Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
c935a08807c1336a3cfd74e0.t81C-xXVlNDfm5CinULcojR1y5sYQYe3rBXo-M3IAAA.z7gTlHSc2YaNyaPn_HqakBkHiPIoOar5-lqEyom4RU31mhaiIIbHob7z4w
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 18.42 | 476,752 | 5,671,581 |
| 15:59:59 | 18.42 | 300 | 5,194,829 |
| 15:59:59 | 18.42 | 100 | 5,194,529 |
| 15:59:59 | 18.42 | 100 | 5,194,429 |
| 15:59:59 | 18.42 | 200 | 5,194,329 |
| 15:59:58 | 18.42 | 100 | 5,194,129 |
| 15:59:58 | 18.42 | 100 | 5,194,029 |
| 15:59:58 | 18.42 | 100 | 5,193,929 |
| 15:59:58 | 18.42 | 100 | 5,193,829 |
| 15:59:58 | 18.42 | 100 | 5,193,729 |
Price Extremes
| 1 week | 16.8 |  | 18.83 |
| 1 month | 12.07 | | 18.83 |
| Current year | 12.07 | | 29.23 |
| 1 year | 12.07 | | 29.23 |
| 3 years | 1.64 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
Monthly variations
Annual variations
| 2026 | +5.32% | ||
| 2025 | -1.99% | ||
| 2024 | +583.72% | ||
| 2023 | -38.59% | ||
| 2022 | +57.99% | ||
| 2021 | -42.77% | ||
| 2020 | +193.75% | ||
| 2019 | +39.13% | ||
| 2018 | -89.62% | ||
| 2017 | +29.44% | ||
| 2016 | -25.57% | ||
| 2015 | +11.76% |
- Stock Market
- Stocks
- SMMT Stock
- Quotes Summit Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
